Overview

Update
Status
Pervasis Therapeutics has been closed
Total Equity Funding
$40.03M in 4 Rounds from 4 Investors
Headquarters:
Cambridge, MA
Description:
Pervasis Therapeutics is a clinical stage company offering a broad portfolio of biologically active therapeutics.
Categories:
Therapeutics, Biotechnology, Medical
Website:
http://www.pervasistx.com

Company Details

Update

Pervasis Therapeutics is a clinical stage company developing a broad portfolio of biologically active therapeutics. Building on its deep understanding of the specialized role that the endothelium plays in regulating natural healing and repair processes associated with disease, Pervasis is advancing groundbreaking new therapies to dramatically improve the outcomes of common vascular interventions, such as arteriovenous access, angioplasties, stents, and peripheral and coronary bypass grafts – the failure of which result in serious complications and a significant increase in medical costs.

Funding Rounds (4) - $40.03M

Update
DateAmount / RoundValuationLead InvestorInvestors
Aug, 2009$17.38M / Series C3
Jan, 2008$9.75M / Venture4
Aug, 2005$12.4M / Series B3
Mar, 2004$500k / Seed2

Offices/Locations (1)

Update
  • Office

    One Kendall Square, Ste. B6101

    Cambridge, MA 02139

    USA

Images (1)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos